• Simvastatin (Zocor) in Cancer and Lipid Research: Protocols

  2026-05-24

  Simvastatin (Zocor) bridges cholesterol-lowering research and oncology, enabling advanced studies in apoptosis and autophagy modulation. This guide delivers stepwise workflows, protocol enhancements, and actionable troubleshooting for maximizing experimental yield with APExBIO's high-purity Simvastatin.

• Sodium Overload Disrupts Mitochondrial Metabolism to Drive N

  2026-05-23

  Qiao et al. reveal that sodium influx through TRPM4 channels triggers a unique necrotic program—NECSO—by suppressing mitochondrial energy metabolism. Their findings uncover a mechanistic link between Na+ dysregulation and cell death, offering new insight into the metabolic collapse underlying necrotic pathologies.

• EPI-001: Androgen Receptor N-Terminal Inhibitor for Advanced

  2026-05-22

  EPI-001 is redefining androgen receptor N-terminal domain inhibition by targeting both full-length and variant AR in prostate and triple-negative breast cancer models. Its robust activity across ligand-dependent and independent pathways, along with practical workflow advantages, uniquely positions it for translational cancer research.

• Bufalin Targets STK33 to Suppress Triple-Negative Breast Can

  2026-05-22

  This study identifies Serine/Threonine Kinase 33 (STK33) as a novel, druggable protein target of Bufalin in triple-negative breast cancer (TNBC). The research elucidates Bufalin's mechanism as a selective degrader of STK33, providing a mechanistic basis for its anti-TNBC effects and revealing a new therapeutic strategy for this aggressive cancer subtype.

• Naloxone Hydrochloride: Advanced Workflows for Opioid Antago

  2026-05-21

  Naloxone hydrochloride from APExBIO empowers researchers with superior receptor subtype targeting and reproducible results for opioid signaling, neural stem cell, and immune modulation assays. This article delivers actionable workflows, troubleshooting tips, and comparative insights—optimized for experimental rigor and research impact.

• Weight Loss Restores Intestinal Stretch-Induced Satiety in O

  2026-05-21

  This study demonstrates that intestinal stretch acutely suppresses food intake and enhances glucose tolerance, but these effects are blunted in obesity and restored after weight loss. The findings reveal a GLP-1-independent mechanism for satiety and glycemic regulation, informing metabolic research and potential interventions.

• Miltefosine Unlocks Neutrophil Differentiation via PI3K/Akt

  2026-05-20

  Miltefosine (hexadecyl 2-(trimethylazaniumyl)ethyl phosphate) uniquely bridges PI3K/Akt inhibition and Ras/MEK/ERK activation for enhanced neutrophil differentiation and immune recovery, as demonstrated in recent translational hematology research. This guide details optimized experimental workflows, troubleshooting strategies, and next-generation use cases, setting a new standard for laboratory protocols in both oncology and immunology.

• Pol II Degradation Triggers Cell Death Beyond Transcription

  2026-05-20

  The reference study demonstrates that targeted degradation of RNA Polymerase II (Pol II) activates cell death independently from global transcription inhibition. This mechanistic insight redefines how the DNA damage response and cell fate are linked, with implications for cancer biology research and therapeutic targeting of transcriptional machinery.

• AIBP-LRP2–HDL Uptake Restricts CXCR4+ Capillary Expansion in

  2026-05-19

  This study reveals that AIBP-LRP2–mediated HDL uptake limits the expansion of stem-like CXCR4+ capillary endothelial cells, thereby restricting collateral vessel formation in ischemic muscle. The mechanistic insight into lipid metabolism and vascular remodeling offers new therapeutic angles for enhancing tissue revascularization in diseases like peripheral artery disease.

• Lysosomal Exocytosis and Growth Factor Signaling in MPS IVA

  2026-05-19

  This study uncovers how enhanced lysosomal exocytosis and altered growth factor signaling contribute to cartilage pathology in a zebrafish model of mucopolysaccharidosis type IVA (MPS IVA). By dissecting the interplay between lysosomal dynamics and skeletal tissue development, the research provides mechanistic insight relevant to lysosomal storage disorders and highlights potential assay strategies for further investigation.

• Estradiol (A8425): Molecular Pathways and Precision Assay Im

  2026-05-18

  Unlock the molecular complexity of estradiol in estrogen receptor signaling and organ protection. This article offers a mechanistic deep dive into 17 beta-estradiol’s roles, with advanced assay guidance for translational research.

• MK-2206 dihydrochloride: Advancing Immune Modulation Researc

  2026-05-18

  This thought-leadership article explores MK-2206 dihydrochloride's pivotal role in dissecting the PI3K/Akt/mTOR signaling pathway, with a focus on its translational impact in immune evasion, cancer apoptosis, and chronic infection research. By synthesizing recent mechanistic findings—including how pathogens like Bordetella spp. exploit the Akt/mTOR axis for immune persistence—this piece offers actionable guidance and strategic insight for translational researchers seeking robust, reproducible results with APExBIO’s MK-2206.

• ETS1 Regulates Mitophagy via SENP2/HSPA8/FUNDC1 to Ameliorat

  2026-05-17

  This study reveals that ETS1, a transcription factor, protects against bronchopulmonary dysplasia (BPD) by inhibiting mitochondrial damage-induced autophagy through the SENP2/HSPA8/FUNDC1 pathway. The work establishes ETS1 as a critical regulator of mitophagy in lung development, offering new mechanistic insight and future directions for targeted autophagy research.

• AM 281: Precision CB1 Cannabinoid Receptor Antagonist Workfl

  2026-05-16

  AM 281 empowers neuropharmacology research with unrivaled selectivity and reproducibility as a CB1 cannabinoid receptor antagonist. This guide spotlights actionable workflows, troubleshooting strategies, and the translational impact of AM 281 in models of memory impairment and traumatic brain injury.

• Cyclophilin A Essential for Cyclosporin A-Mediated Immunosup

  2026-05-15

  This study demonstrates that the immunosuppressive effects of Cyclosporin A depend specifically on Cyclophilin A, using gene-deficient mouse models. These findings clarify cyclosporin’s mechanism and have direct implications for research on T-cell signaling, immunosuppression, and transplantation models.

450 records 17/30 page Previous Next First page 上5页 1617181920 下5页 Last page